Activists Diagnose Pharma Difference Bewixt Rep. Sharice Davids Vs. Dr. Reddy

TKC doesn't make endorsements and this post should leave EVERYONE feeling a bit ill about the upcoming election . . . In the meantime, this post is mostly just an unsigned advertorial with a few interesting tidbits . . .

During the Reddy-Davids campaign, an issue has been made of Reddy’s 2023 financial disclosure statement that indicated he owned as much as $651,000 in stock in pharmaceutical and laboratory science companies like LabCorp. Davids’ campaign said she didn’t possess drug company stock.

Reddy, a cancer physician, reported receiving $78,000 in consulting fees, travel, lodging and dining payments from drug or medical device companies in the past.

Reddy’s congressional campaign raised more than $400,000 from political interests aligned with pharmaceutical companies opposed to capping the price of insulin for seniors.

“It’s clear Kansans can’t trust Prasanth Reddy to cut drug costs when he’s been paid by the very companies raising them,” said Zac Donley, a spokesperson for Davids. “While Reddy is cozy with Big Pharma, Sharice Davids is standing up to these large drug companies and working to lower prescription prices for Kansas families.”

Read more via www.TonysKansasCity.com link . . .

Davids-Reddy campaign in Kansas a prescription for debate on remedies to high drug prices * Kansas Reflector

Democrat Sharice Davids and Republican Prasanth Reddy debate a 2022 federal law reducing prescription costs for seniors and capping prices on 10 drugs.